Detalhe da pesquisa
1.
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.
Ann Oncol
; 29(6): 1423-1430, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29648580
2.
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma.
Ann Oncol
; 28(11): 2827-2835, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950289